Neuroleptic malignant syndrome-like condition in multiple system atrophy.
Konagaya
M
M
Goto
Y
Y
Matsuoka
Y
Y
Konishi
T
T
Konagaya
Y
Y
D000978:Antiparkinson Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017072:Neostriatum / Q000503:physiopathology*; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D009849:Olivopontocerebellar Atrophies / Q000150:complications*; D010300:Parkinson Disease / Q000150:complications*; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D013378:Substantia Nigra / Q000503:physiopathology*
D000978:Antiparkinson Agents